(Q48025176)

English

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

author name string

Bishara A

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

De Santis D

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Witt CC

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Brautbar C

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Christiansen FT

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Or R

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Nagler A

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Slavin S

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

publication date

1 March 2004

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Tissue Antigens

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

63

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

204-211

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

HLA class I specific inhibitory receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

NK cell receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Human diversity in killer cell inhibitory receptor genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Linomide administration following bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00182.X

21 January 2018

Identifiers

10.1111/J.0001-2815.2004.00182.X

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/14989709

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48025176&oldid=1364878573"